Elevance Health Inc. (ELV) Q2 FY26 Earnings Call

Guidance increased, but Medicaid utilization remains elevated and portfolio exits underscore ongoing execution risk [4][55].

Q2 FY26 results, source: company transcript and SEC filings
QuarterQ2 FY26
Call date2026-07-15
Length64 minutes
EPS$7.45
EPS consensus$6.18
Revenue$50.5B

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q1 FY26 · Q4 FY25 · Q3 FY25 · Q2 FY25 · Q1 FY25

All ELV earnings · Back to ELV overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.